By Vincent Cruz

No foreign brands underestimate the U.S. market quite like Canadian ones. You share a border, a language, a time zone map, and most of a supply chain with the United States, so it feels like selling south should be a shipping decision, not a regulatory project. It is a regulatory project. Health Canada and FDA run separate cosmetics systems with separate filings, and the trade agreements between the two countries say nothing about harmonizing them.

This guide is written for the Canadian brand owner planning to sell in the U.S.: what MoCRA requires of you, where the Canadian and U.S. systems diverge, and the specific mistakes that catch Canadian brands. For the full compliance picture, start with the MoCRA Compliance Guide for Cosmetic Brands.

The core rule: your Health Canada notification does not transfer

Everything in this guide follows from one fact: FDA does not recognize Canadian compliance as a substitute for U.S. compliance. Specifically:

Your Cosmetic Notification Form (CNF) means nothing to FDA. The notification you filed with Health Canada within 10 days of first selling in Canada is a Canadian record. The U.S. has its own product listing system, with different data and different legal weight.
Hotlist compliance is not U.S. compliance. Canada’s Cosmetic Ingredient Hotlist restricts and prohibits ingredients for the Canadian market. FDA has its own, shorter list of prohibited and restricted ingredients, plus state rules (California’s Proposition 65 and cosmetic-specific laws) that have no Canadian equivalent. An ingredient can be fine in Canada and a problem in the U.S., and the reverse.
There is no Canadian equivalent of facility registration or the U.S. agent. Canada does not register cosmetic manufacturing facilities with the federal government and does not require a domestic agent for cosmetics. MoCRA requires both. Nothing in your Canadian setup covers either one.
USMCA does not help. The trade agreement covers tariffs and market access. It does not merge the two countries’ cosmetics laws, and it does not exempt Canadian facilities from a single MoCRA filing.

Plan your U.S. launch as a fresh compliance project, not a cross-border extension of your Canadian one.

Step 1: Register your facility with FDA

If your products are manufactured or processed in Canada (or anywhere outside the U.S.) for sale in America, the facility must register with FDA. Key points for Canadian brands:

You need an FEI number first. The FDA Establishment Identifier is required before registration can be filed. Request it from FDA by email; processing typically takes 7 to 10 business days. Run the free FEI check to see whether your facility already has one.
Registration is filed through Cosmetics Direct, FDA’s online portal, using Form FDA 5066. The step-by-step process is covered in Cosmetics Direct: How to Register Your Facility.
Registration renews every two years, based on your facility’s initial registration date, with automated reminders from FDA. See MoCRA Biennial Renewal Explained.
Using a Canadian contract manufacturer? The facility that manufactures the product is the one that registers. If a lab in Ontario or Quebec makes your products, that lab’s facility registers, and it needs its own U.S. agent. See Private Label Cosmetics: Who Registers Under MoCRA.

A common Canadian-brand mistake: assuming that because your products already cross the border for Canadian distribution, or because your U.S. distributor is FDA-registered for other lines, your facility is covered. It is not. The manufacturing facility registers in its own name.

Step 2: Name a U.S. agent

Every foreign facility registering with FDA must designate a U.S. agent: a person or business physically present in the United States who serves as FDA’s official contact for the facility. This is not optional, and a Canadian address, even one an hour from the border, cannot fill the role.

The agent receives FDA correspondence, relays it to you, and is the contact FDA reaches out to with questions about your facility. This is the requirement Canadian brands most often discover late, because nothing in the Canadian system resembles it. For how to evaluate providers, see How to Choose a MoCRA U.S. Agent and Who Can Be a MoCRA U.S. Agent.

Step 3: List your products

Each cosmetic product sold in the U.S. must be listed with FDA through Cosmetics Direct (Form FDA 5067), filed by the responsible person (the manufacturer, packer, or distributor whose name appears on the label). Listings include product and ingredient information and must be kept current with annual updates.

The comparison that trips Canadian brands up: your CNF is a notification filed after you start selling, and Health Canada filing it does not approve your product. The U.S. listing looks superficially similar but is a distinct filing in a distinct system, and marketplaces and retailers in the U.S. increasingly ask for proof of it. For how registration and listing differ, see Facility Registration vs Product Listing Explained.

Step 4: Fix your labels for the U.S. market

Canadian labels come closer to U.S. compliance than most, but “close” still fails. The differences that matter most:

Language. Canada requires bilingual English/French labeling. The U.S. requires all mandatory information in English. Your French text can stay, but nothing required may appear only in French, and the English panel must meet U.S. placement and prominence rules on its own.

Net quantity. Canadian labels are metric. U.S. consumer commodities must state net quantity in both U.S. customary and metric units, placed in a specific location on the principal display panel. Metric-only labels need updating.

Ingredient declaration. Both countries use INCI nomenclature, so your ingredient list mostly transfers. But the U.S. requires descending order of predominance with specific formatting rules, and an ingredient restricted on Canada’s Hotlist is not automatically legal or illegal in the U.S.; each formula needs its own check against U.S. federal and state rules.

Name and place of business. The label must show the name and place of business of the manufacturer, packer, or distributor. A Canadian address alone is acceptable only if the product is not misleading about origin; many Canadian brands add their U.S. distributor’s information.

Warnings and claims. Canada requires its own cautionary statements for certain products; U.S. law requires its own. And claims written for the Canadian market, especially anything touching acne, eczema, hair regrowth, or pain relief, can be drug claims in the U.S. See Is Your Product a Cosmetic or a Drug?.

For the detailed labeling changes MoCRA introduced, see MoCRA Labeling Changes.

The pitfalls that catch Canadian brands specifically

The proximity myth. Shared border, shared language, shared retailers, one trade agreement, zero shared cosmetics law. Every Canadian brand that gets detained at the border or delisted by a U.S. retailer started from this assumption.
Sunscreen and drug products. In Canada, sunscreens are drugs with a Drug Identification Number (DIN), or natural health products with an NPN. In the U.S. they are also drugs, but under FDA’s own system: your DIN or NPN does not transfer, Drug Facts labeling replaces the Canadian format, and drug facility registration replaces the cosmetics one. Same category, different everything.
Assuming the CNF was an approval. It was not one in Canada, and it is not one in the U.S. either. But U.S. retailers and Amazon increasingly request your FDA listing and registration details before onboarding, which is a practical gate even where FDA itself is not pre-approving anything.
Relying on the distributor. Your U.S. distributor or retail partner may offer to “handle compliance.” They cannot register your Canadian facility or serve as your facility’s U.S. agent unless they formally take on that role and meet FDA’s requirements. Keep control of your own filings.
Small-business exemption confusion. The U.S. small-business exemption (Section 612 of the FD&C Act, 21 U.S.C. section 364h) is based on U.S. sales, not Canadian revenue, and it never exempts labeling, safety substantiation, or adverse event reporting. Check the exemption worksheet rather than assuming.
Forgetting the ongoing duties. Registration is not a one-time event: biennial renewal, annual listing updates, adverse event reporting within 15 business days for serious events, and record-keeping that FDA can demand to see. See MoCRA Adverse Event Reporting.

A realistic Canada-to-US launch sequence

Classify every product as cosmetic or drug for the U.S. market (re-do claims and ingredients, not just labels). DIN/NPN products get decided first.
Confirm whether you qualify for the small-business exemption; if not, proceed with full compliance.
Request your facility’s FEI number (7 to 10 business days).
Choose and appoint your U.S. agent.
File facility registration via Cosmetics Direct.
File product listings.
Finalize U.S.-compliant labels before the first shipment.
Set up adverse event intake and record-keeping from day one.

For realistic timing on each step, see How Long Does MoCRA Facility Registration Take?.

FAQ

Do I need a U.S. agent if I sell through an American distributor?
Yes, if your products are manufactured outside the U.S. The foreign manufacturing facility must designate its own U.S. agent as part of facility registration. Your distributor cannot substitute for this unless it formally serves as the agent and meets FDA’s requirements.

Does my Cosmetic Notification Form count as a U.S. product listing?
No. The CNF is a Health Canada record. U.S. product listing is a separate filing made with FDA through Cosmetics Direct, and your CNF has no effect on it.

My facility is 30 minutes from the U.S. border. Can we be our own U.S. agent?
No. The U.S. agent must be physically present in the United States (residing there or maintaining a U.S. place of business). A Canadian address does not qualify, however close to the border it is.

Can I keep my bilingual labels for the U.S.?
Mostly, yes. All mandatory U.S. label information must appear in English and meet U.S. format and placement rules; French text may remain alongside it. Metric-only net quantity statements must be updated to show U.S. customary units as well.

My sunscreen has a DIN. What changes for the U.S.?
In the U.S., sunscreen is regulated as an over-the-counter drug under FDA’s system: drug establishment registration, drug product listing, and Drug Facts labeling. The DIN does not transfer, and the cosmetics pathway in this guide does not apply to it.

How long does the whole process take for a Canadian brand?
The FEI request alone takes 7 to 10 business days, and gathering registration details, appointing an agent, and finalizing labels adds more time. Plan for several weeks minimum from a standing start; see How Long Does MoCRA Facility Registration Take? for the full breakdown.

Next step: Canadian brand planning a U.S. launch? Contact us for a straight assessment of what your products need, or run the free FEI check to confirm whether your facility already has an FDA Establishment Identifier.